ライフサイエンスコーパス: expectancy

1 d against other patient factors such as life expectancy.

2 tary habits in relation to disease-free life expectancy.

3 reduced quality of life, and a shorter life expectancy.

4 risk of suicide, result in a shortened life expectancy.

5 ptoms, and worsening quality of life or life expectancy.

6 ss without treatment from the 11.0-year life expectancy.

7 e been associated with a step-change in life expectancy.

8 years) and a 6-year reduction in median life expectancy.

9 ng of the income-related differences in life expectancy.

10 disorders, which contribute to reduced life expectancy.

11 person-years and a 6-year reduction in life expectancy.

12 annual public direct medical costs and life expectancy.

13 living with HIV now have a much longer life expectancy.

14 ents' stroke risk, hemorrhage risk, and life expectancy.

15 ave both high lung cancer risk and long life expectancy.

16 stimuli with perceptually balanced stimulus expectancy.

17 n lead to profound differences in adult life expectancy.

18 ized treatment selection likely extends life expectancy.

19 entral part of the city had the highest life expectancy.

20 ive risks or crude estimates of reduced life expectancy.

21 t be contributing to the disparities in life expectancy.

22 mortality, and to adjust for changes in life-expectancy.

23 iation between daily PM2.5 exposure and life expectancy.

24 ents with CML to experience near-normal life expectancy.

25 king results in at least a decade lower life expectancy.

26 itnessed an unprecedented rise in human life expectancy.

27 ith the aim of enhancing healthspan and life expectancy.

28 contribution of lifestyle factors on health expectancy.

29 areas of the United States have longer life expectancies.

30 higher social reward and lower social threat expectancies.

31 OG) performance status score of 0 or 1, life expectancy 3 months or longer, and a PD-L1 TPS of 1% or

32 scopy experienced longer 3-year average life expectancy (+6.2%, P = 0.018), and those who live past t

33 ith the lowest 1% income had the lowest life expectancy (70.6 years [95% CI, 69.6-71.6]), which was 1

34 Survival models were applied to predict life expectancy, adjusting for ethnicity, working status, dep

35 Contemporary data on loss in life expectancy after aortic valve replacement (AVR) are scar

36 relative survival and estimated loss in life expectancy after AVR.

37 With increased life expectancy, age-associated cognitive decline becomes a g

38 gression model to compare mortality and life expectancy among patients treated with either bariatric

39 Improvements in life expectancy among people living with human immunodeficien

40 among PLWH could narrow disparities in life expectancy among some key populations, but other causes

41 Despite extensive literature on participant expectancies and other potent psychosocial factors that

42 he relation between social reward and threat expectancies and regional grey matter volumes (rGMV).

43 grew manifold, allowing an increase in life expectancy and a better life quality for humans and anim

44 d people with HIV is likely to increase life expectancy and be cost-effective at the currently antici

45 alised patients with HIV could increase life expectancy and be cost-effective in resource-limited set

46 rovements and long-run quality-adjusted life expectancy and costs.

47 We found an interaction of expectancy and delivery on pain improvement following th

48 High baseline outcome expectancy and home ownership predicted overall prepared

49 n-111 protein results in an increase in life expectancy and improvements in muscle pathology and func

50 central part of the city had the lowest life expectancy and in Belo Horizonte the central part of the

51 esults demonstrate that both changes in life expectancy and life span equality are weighted totals of

52 In recent decades, life expectancy and life span equality have occasionally move

53 The link between life expectancy and life span equality is especially strong w

54 e develop a unifying framework to study life expectancy and life span equality over time, relying on

55 study the dynamic relationship between life expectancy and life span equality with reliable data fro

56 recent exceptions to the joint rise of life expectancy and life span equality, however, make it diff

57 xpectancy is the key to increasing both life expectancy and life span equality.

58 which reductions in mortality increase life expectancy and life span equality: the more progress at

59 to a microsimulation model to calculate life expectancy and lifetime event risk for the ages of 25, 3

60 Life expectancy and long-term costs associated with device re

61 suggest that younger patients with long life expectancy and low-perioperative risk may benefit more f

62 providing both greater quality-adjusted life expectancy and lower long-term costs than SAVR.

63 nosis that is likely related to limited life expectancy and physical limitations in ALS patients.

64 ry mitral regurgitation, TMVr increases life expectancy and quality-adjusted life expectancy compared

65 ive contribution to the prolongation of life expectancy and quality.

66 comparison to normosmia controls (NC) during expectancy and reading of odor-associated words.

67 IA, and 16 NC healthy participants during an expectancy and reading task.

68 tioned fear learning was quantified by shock expectancy and skin conductance response (SCR).

69 Death) clock, which accurately predicts life expectancy and the efficacy of a lifespan-extending inte

70 cially in light of the increases in the life expectancy and the incidence of comorbidities in this po

71 Zimbabwe will improve survival, extend life expectancy, and be cost-effective for HIV-exposed infant

72 health, cognitive performance, overall life expectancy, and increases vulnerability to Alzheimer's d

73 el inputs: infection-related mortality, life expectancy, and infection cost.

74 followed by high neuroticism, low treatment expectancy, and low perception of the therapist as accep

75 outcomes were self-reported fear and threat expectancy, and neural responses during conditioned stim

76 or burden, degree of liver dysfunction, life expectancy, and patient preferences.

77 of mortality, direct medical costs, and life expectancy are unknown.

78 In hypnotic responding, expectancies arising from imaginative suggestion drive s

79 The control of phenomenology to meet expectancies arising from perceived task requirements ca

80 HIV-free life expectancy at age 15 years improved significantly during

81 Between 2010 and 2017, life expectancy at age 25 significantly declined among white

82 In contrast, life expectancy at age 25 significantly increased among the c

83 stagnation held back the increase of US life expectancy at age 25 y by 1.14 y in women and men, betwe

84 serial cross-sectional study, estimated life expectancy at age 25 years declined overall between 2010

85 70%, 160%, and 280%, respectively; and life expectancy at age 60 years decreased by about 5, 10, and

86 e between the ninth and first decile of life expectancy at birth (P90-P10 gap) across subcity units i

87 have focused on broad measures, such as life expectancy at birth and child and infant mortality, and

88 evident in the effects of low supply on life expectancy at birth and high mortality across ages, even

89 e also analysed the association between life expectancy at birth and socioeconomic status at the subc

90 We calculated average life expectancy at birth by sex and subcity unit with life ta

91 Life expectancy at birth increased by 5.4 (95% UI 3.7-7.2) ye

92 2016, and actuarial data for remaining life expectancy at the age of death.

93 ls were used to estimate sex-specific health expectancy at the ages of 50, 60 and 70.

94 lated mortality would have the greatest life-expectancy benefit for black men who have sex with men,

95 ality with cardiometabolic disease-free life expectancy between ages 50 and 85 y.

96 iated with cardiometabolic disease-free life expectancy between ages 50 and 85.

97 There was no difference in loss in life expectancy between men and women.

98 The largest differences in life expectancy between Norway and United States were for ind

99 Differences in life expectancy between the top and bottom 5% of the cPRS wer

100 ll strive to equitably increase healthy life expectancy beyond current projections, with global and l

101 Current treatments increase life expectancy but have limited impact on the progressive pu

102 retrospective pain ratings show an effect of expectancy but not of delivery.

103 HIV testing alone increased life expectancy by 0.07-0.30 years in MSM; PrEP added approxi

104 th CVD) was projected to increase their life expectancy by 0.19 (0.14-0.23) and 0.90 (0.50-1.21) year

105 Xpert+AlereLAM, Xpert+FujiLAM increased life expectancy by 0.2 years for those tested in South Africa

106 The intervention increased life expectancy by 0.5-1.2 years and was cost-effective, with

107 horizon, TMVr was projected to increase life expectancy by 1.13 years and quality-adjusted life-years

108 5-year PFS, tisagenlecleucel increased life expectancy by 4.6 years at $168,000/QALY gained (95% unc

109 -free survival (PFS), axi-cel increased life expectancy by 8.2 years at $129,000/QALY gained (95% unc

110 We also examined life expectancy by age at diagnosis.

111 med to assess the potential benefits in life expectancy by attaining the daily PM2.5 standards in 72

112 From 2005 to 2015, the differences in life expectancy by income increased, largely attributable to

113 were substantial and increasing gaps in life expectancy by income level from 2005 to 2015.

114 Differences in life expectancy by income levels in Norway were similar to di

115 Along with extended life expectancy comes a growing population that is experienci

116 etes had higher risk of death and lower life expectancy compared to the general population.

117 es life expectancy and quality-adjusted life expectancy compared with GDMT at an incremental cost per

118 te endurance athletes have an increased life expectancy compared with the general population.

119 During the expectancy condition of OW, IA and NC groups showed stro

120 sions from ages 15-30, quality-adjusted life expectancy, costs, and incremental cost-effectiveness ra

121 udy indicates that significantly longer life expectancy could be achieved by a reduction in the ambie

122 The recent decrease in US life expectancy culminated a period of increasing cause-speci

123 Life expectancy data for 1959-2016 and cause-specific mortali

124 un violence epidemic and reverse recent life expectancy declines among Americans.

125 e rate of increase slowed over time and life expectancy decreased after 2014.

126 evel of income, the largest part of the life expectancy deficit was produced by working-age mortality

127 D.C.; second, we decomposed black-white life expectancy differences into 23 causes of death in three

128 s to live male births by year of birth, life expectancy disadvantage as a 1 - ratio of prevalence to

129 The life expectancy disadvantage for high-income countries is 30%

130 Patients with hemophilia still have a life expectancy disadvantage.

131 We calculate the impact on period life expectancy (down 2.94 y) and remaining life years (11.7

132 tive cognitive control task (the Dot Pattern Expectancy (DPX) Task), after receiving 20 min of active

133 selects older ever-smokers with shorter life expectancies due to comorbidities.

134 ain-processing circuits to underlie stimulus expectancy effects on pain, with positive and negative e

135 y applied an automated protocol for inducing expectancy effects on pain.

136 eaten the research of mechanisms involved in expectancy effects on pain.

137 unction, routine PN yielded the longest life expectancy (eg, 0.67 years in 65-year-old men with nephr

138 idance for active surveillance extended life expectancy (eg, 2.60 years for MRI vs PN in CKD 3a, NS 1

139 active surveillance for growth extended life expectancy (eg, 2.70 years for surveillance for growth i

140 Whether changes in musical expectancy elicit pleasure has thus remained elusive [11

141 nomic status was associated with higher life expectancy, especially in Santiago (change in life expec

142 s debilitating and associated with poor life expectancy, especially in those with cardiac dysfunction

143 economic value of an additional year of life expectancy; estimated total implementation costs; and de

144 d cause-specific mortality and HIV-free life expectancy estimates from the Global Burden of Diseases,

145 stocytosis (ISM) patients have a normal life expectancy, except in the 5% to 10% of cases that progre

146 f pretreatment VS dynamic response to reward expectancy (expected outcome value) and prediction error

147 uality and cardiometabolic disease-free life expectancy followed a dose-response pattern and was obse

148 During this task we measured participants' expectancies for social reward (anticipated feelings of

149 06 (95% CI: 0.04-0.07) years of gain in life expectancy for each death in these cities.

150 The marked increase in life expectancy for HIV-1 seropositive individuals, following

151 the only intervention shown to increase life expectancy for patients with IPF, but it is associated w

152 However, although life expectancy for people with cystic fibrosis has increased

153 k of any NCD, age at onset, and overall life expectancy for strata of 3 shared risk factors at baseli

154 Critically, weight gain may reduce life expectancy for up to 20-30 years in patients with psycho

155 Over the same period, life expectancy for women in the highest income quartile incr

156 ased 3.2 years (95% CI, 2.7-3.7), while life expectancy for women in the lowest income quartile decre

157 We used per-capita GDP (PPP) and life expectancy from 61 countries in 2014-15, plus those of R

158 477-515 cells/uL) and quality-adjusted life expectancy from age 15 (44.4 to 48.3-48.7 years) among Y

159 x-specific cardiometabolic disease-free life expectancy from age 50 to 85 y for each AHEI-2010 quinti

160 The net increase in life expectancy from offering early transplantation was highe

161 id of CVD mortality declines, future US life expectancy gains must come from other causes-a monumenta

162 ished by about 25% since 2005, when the life expectancy gap was 8.9 years for Russia and 6.6 years fo

163 pinal cord or cauda equina compression, life expectancy greater than 8 weeks, and no previous radioth

164 fficient for achieving pre-2010 pace of life expectancy growth.

165 Although the black-white gap in life expectancy has been shrinking in the U.S., national impr

166 y in 2020 will remain higher than Black life expectancy has ever been unless nearly 700,000 excess Wh

167 mmon chromosomal condition, and average life expectancy has increased substantially, from 25 years in

168 However, as human life expectancy has increased, so has the number of immunocom

169 US life expectancy has not kept pace with that of other wealthy

170 Patient life expectancy has recently increased, but the need for chro

171 Positive and negative social expectancies-imagining new social interactions to be rew

172 Life expectancy improved from 48 to 69 years, infant mortalit

173 urrence of PF to correlate with inferior OAS expectancies in adult but not in pediatric patients.

174 Life expectancy in 2015 for both Russia and Moscow lay below

175 Moreover, White life expectancy in 2020 will remain higher than Black life ex

176 the impact of TAVR valve durability on life expectancy in a cohort of low-risk patients similar to t

177 trongly associated with shorter healthy life expectancy in both countries, attesting to the robustnes

178 s abnormally elevated activity during reward expectancy in individuals with Bipolar Disorder.

179 Large spatial differences in life expectancy in Latin American cities and their associatio

180 ght significantly contribute to reduced life expectancy in low-income and middle-income countries (LM

181 of surgical valves to result in reduced life expectancy in patients with demographics similar to thos

182 he leading contributor to the shortened life expectancy in patients with severe mental illness (SMI),

183 ociations between healthy lifestyle and life expectancy in people with and without multimorbidity.

184 bjective was to examine inequalities in life expectancy in six large Latin American cities and its as

185 The adjusted median life expectancy in the surgery group was 3.0 years (95% CI, 1

186 ng with HIV/AIDS (PLWHA) have a growing life expectancy in the US due to early provision of effective

187 icant factors underlying the decline in life expectancy in the US.

188 icability of TAVR in patients with long life expectancy in whom THV durability may be a concern.

189 the impact of TAVR valve durability on life expectancy in younger age groups (40, 50, and 60 years).

190 For men, life expectancy increased 3.1 years (95% CI, 2.5-3.7) in the

191 US life expectancy increased for most of the past 60 years, but

192 Between 1959 and 2016, US life expectancy increased from 69.9 years to 78.9 years but d

193 The estimated loss in life expectancy increased with younger age: 0.4 years (95% CI

194 s), which becomes more favorable as the life expectancy increases beyond 6 years.

195 Increasing life expectancy is causing the prevalence of age-related dise

196 In Indonesia, the average life expectancy is less than 5 months, with most patients bei

197 span equality is especially strong when life expectancy is less than 70 y.

198 aining a major burn injury on long-term life expectancy is poorly understood.

199 ign medications with goals of care when life expectancy is reduced.

200 Saving lives at ages below life expectancy is the key to increasing both life expectancy

201 lative risk of death, but its effect on life expectancy is unclear.

202 transplant recipients (SOTR), and their life expectancy, is increasing, with higher risk for long-ter

203 eness (PA)-the understanding of limited life expectancy-is critical for effective goals of care discu

204 comorbidities may aim for a near-normal life expectancy, just as the more select patients enrolled in

205 optimize the ability of organisms to update expectancies later in life.

206 ced neural sensitivity to violations of word expectancy, leading to reduced condition effects for tem

207 At any PM2.5 concentration, life expectancy loss was, on average, larger in counties with

208 Between sessions, they received an expectancy manipulation (placebo or no-treatment) delive

209 This points to the diversity of expectancy mechanisms, and has implications for research

210 degree experienced similar declines in life expectancy (men: -0.89 years [95% CI, -1.07 to -0.73], w

211 We estimated life expectancies of patients receiving early vs delayed tran

212 , and intestinal rupture and an average life expectancy of <50 years.

213 55 life years, compared with an average life expectancy of 1.46 life years for patients offered delay

214 ed 75 years or older or in women with a life expectancy of 10 years or less, clinicians should discon

215 older than 75 years or in adults with a life expectancy of 10 years or less.

216 a In Solid Tumors (irRECIST), and had a life expectancy of 12 weeks or longer.

217 p performance score of 1 or less, and a life expectancy of 12 weeks or more.

218 ed to a microsimulation-based estimated life expectancy of 21 years (general population: 32 years) an

219 ation were estimated to have an average life expectancy of 6.55 life years, compared with an average

220 al, reaching $43 000 in 2015 and with a life expectancy of 75.5 years.

221 Gun violence has shortened the average life expectancy of Americans, and better knowledge about the

222 espan (lifespan setpoint) determine the life expectancy of any given organism.

223 ogy Group performance status of 0 or 1, life expectancy of at least 3 months, adequate organ function

224 logy Group performance status of 0-2, a life expectancy of at least 3 months, and at least one measur

225 d platinum-based chemotherapy and had a life expectancy of at least 3 months.

226 tive Oncology Group score of 0-1, and a life expectancy of at least 6 months were eligible.

227 ogy Group performance status of 0 or 1, life expectancy of at least 6 months, and adequate haematolog

228 insensitivity to chemotherapy, shortens life expectancy of cancer patients.

229 oviral therapy (cART) has increased the life expectancy of HIV patients.

230 The increasing life expectancy of individuals with Cystic Fibrosis (CF) is l

231 compared mortality rates and decline in life expectancy of Iranian patients with type 2 diabetes (T2D

232 -targeted treatment for patients with a life expectancy of less than 10 years.

233 lation model was constructed to compare life expectancy of management strategies for small renal tumo

234 cology Group performance status of 0-2, life expectancy of more than 12 weeks, and newly diagnosed In

235 of child loss is accompanied by reduced life expectancy of parents in contemporary affluent populatio

236 Increased life expectancy of patients diagnosed with HIV in the current

237 Although the life expectancy of patients with follicular lymphoma (FL) has

238 in standards of care have extended the life expectancy of patients with kidney failure.

239 n-invasive metrics that can predict the life expectancy of pre-clinical models.

240 Overall life expectancy of women ranged from 18.0 years (95% confiden

241 ive human malignancies, with an average life expectancy of ~6 months from the time of diagnosis.

242 d are associated with an alarmingly low life expectancy (on average only 2 years from the amputation)

243 plore the brain activation in response to OW expectancy or OW reading between groups (CW as baseline)

244 ling years) on a variety of disease and life-expectancy outcomes.

245 In a stimulus expectancy paradigm combining fMRI in healthy volunteers

246 Using fMRI in a stimulus expectancy paradigm, we found that, although positive an

247 uctions in firearm deaths would improve life expectancy, particularly for black men in the USA, and w

248 h, predicted quality of life, predicted life expectancy, patient preferences, and other patient facto

249 ng high comorbidity rates and shortened life expectancy, patients with ESKD may harbor unrealisticall

250 ancy, especially in Santiago (change in life expectancy per P90-P10 change unit-level of educational

251 urther estimated the potential gains in life expectancy (PGLE) by assuming that ambient PM2.5 has met

252 to be inversely linked to the remaining life expectancy, potentially resulting in a terminal effort i

253 nt after muscle disease onset increased life expectancy, promoted muscle growth and increased muscle

254 We aimed to estimate quality-adjusted life expectancy (QALE) loss due to dental conditions in the U

255 mon practice due to its great impact on life expectancy, quality of life and healthcare costs.

256 For men, life expectancy ranged from 15.6 years (95% CI: 15.4, 15.9) a

257 With freshwater mussel life expectancy ranging from a few years up to 200 years, thi

258 the left somatosensory cortex reduces reward expectancy-related activity and negative affect post tDC

259 odal tDCS over the left vlPFC lowered reward expectancy-related left ventral striatal activity (F(1,5

260 CANCE STATEMENT As a result of enhanced life expectancy, researchers have devoted increasing attentio

261 nsplant to selected patients who have a life expectancy shorter than the time it would take for them

262 isability-free and chronic disease-free life expectancy similarly in two longitudinal studies of agei

263 We compared sex-specific trends in life expectancy since 1970 and age-specific mortality in Engl

264 countries have seen slower increases in life expectancy since 2011, trends in England and Wales are a

265 In 2011-16, the rate of improvement in life expectancy slowed sharply for both sexes in England and

266 ecades of robust growth, the rise in US life expectancy stalled after 2010.

267 fort negatively covaries with remaining life expectancy, supporting optimality theory and confirming

268 6 of the comparator countries but lower life expectancy than 60 comparator countries.

269 tric surgery was associated with longer life expectancy than usual obesity care.

270 Although PLHIV are experiencing longer life expectancies, this achievement may be undermined by incr

271 agnosis improved projected undiscounted life expectancy to 25.5 years among infants with HIV and 62.6

272 With increasing life expectancy, TTNtv-associated morbidity and mortality wil

273 In contrast, social threat expectancies uniquely correlated with rGMV of regions in

274 behavior, including assessment of (1) reward expectancy using a food-related anticipatory activity ta

275 We adjusted life expectancy values for Moscow for underestimation of mort

276 n the observed and the Preston-expected life expectancy values for Russia have diminished by about 25

277 t life and do not quit lose a decade of life expectancy versus non-smokers.

278 rwise, personalized strategies extended life expectancy versus routine PN: in CKD stages 2 or 3a, mod

279 cenario, the standardized difference in life expectancy was <0.10 between TAVR and SAVR until transca

280 The loss in life expectancy was 1.9 years (95% CI: 1.2 to 2.6 years) in t

281 nfant diagnosis, projected undiscounted life expectancy was 22.7 years for infants with HIV and 62.5

282 daily living and, chronic disease-free life expectancy was based on chronic health conditions.

283 Disability-free life expectancy was estimated using repeat measures of limita

284 erved in the United States, except that life expectancy was higher in Norway in the lower to middle p

285 Life expectancy was highest for women with income in the top

286 ilst early survival was good, long-term life-expectancy was low.

287 ough early survival was good, long-term life expectancy was low.

288 The net increase in life expectancy was maintained in all simulated extreme scena

289 In younger patients, life expectancy was reduced when TAVR durability was 30%, 40%

290 The estimated loss in life expectancy was substantial, and increased with younger a

291 mance status 0-3, and at least 3 months life expectancy were eligible.

292 At a 30% 5-year PFS, improvements in life expectancy were more modest (6.4 years) and expensive ($

293 Endurance capacity and life expectancy were normal.

294 At a 25% 5-year PFS, improvements in life expectancy were smaller (3.4 years) and more expensive (

295 Reliable population estimates of life expectancy with dementia are required for shaping health

296 was a clear gradient towards shorter health expectancy with increasing number of behavioural risk fa

297 disorders were associated with shorter life expectancies, with excess LYLs ranging from 5.42 years (

298 ated with mortality impacts and loss of life expectancy, with larger impacts in counties with lower i

299 le risk factors equally correlated with life expectancy, with smoking being significantly worse than

300 e is increasing in patients with longer life expectancy, yet robust data on the durability of transca